Recent data suggests that the effect of EphB4 on the metastatic process in malignant melanoma is highly dependent on the absence or presence of its preferred ligand Ephrin-B2, and its effects are primarily related to tumor cell dissemination and not post-seeding processes like the growth of solid metastases [3,7]. This evidence concerns the gene EFNB2 and melanoma.